• Malaria, Molecular Detection, PCR
  • Hereditary Hemolytic Anemia Gene Mutation Panel, NGS
  • Complete Autoimmune (Connective Tissue Autoimmune) Disease Panel
  • Legionella pneumophila Antibody, IgG by IFA
  • Copper, 24 Hour, Urine
  • Beta-Glucuronidase, Fibroblasts
  • Monoclonal Protein Study, 24 Hour, Urine
  • Spondylosis and associated disorders
  • Schizophrenia
  • Malignant neoplasm, adrenal gland
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2)
Medical Test

References
Access to CNBP Genetic Analysis for Myotonic Dystrophy, Type II (DM2) is restricted.